Whilst some research suggests glutathione levels may be reduced in fatty liver disease, current NICE guidance does not recommend glutathione supplementation for non-alcoholic fatty liver disease (NAFLD), and it is not part of standard NHS treatment
As a result, many people suffer from chronic, systemic inflammation
Nuclei were pelleted by centrifugation (650 g, 5 min), supernatant was discarded and the pellet was resuspended in 100 l NUN1 buffer containing 20 mM Tris-HCL (pH = 7.5), 75 mM NaCl, 0.5 mM EGTA, 50 % glycerol, 1x protease and 1x phosphatase inhibitors
O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy
Anti-Inflammatory- May help modulate inflammatory pathways, providing potential relief from conditions associated with chronic inflammation